Replies to post #5210 on LadRx Corp (LADXD)

[wise_investor]

You are correct on the Pre14,

It is all it is, words on paper, these flexible attributes on the preliminary are made to benefit management and placebo investors.

This will change to Mr. Soons advantage, Mr Soon wants CYTR as part of his company portfolio, He bought a stake on CYTR already and payed a 92% premium on the share value as stated on (7/28/17 PR)

He believes the drug he bought on paper jas tremendous potential.

He just wants his money now,

New manahement will make the stock sky rocket

without an RS

Wise